LumiraDx - Next Generation Point-of-Care Diagnostics - homepage
The LumiraDx Platform has been deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, long-term care and hospitals at home to screen, diagnose, and monitor wellness and disease. Our Platform offers next-generation solutions, using cloud-based technology and data to ...
Leading edge innovators in Point of Need - LumiraDx
Roche acquired select parts of the LumiraDx group related to LumiraDx’s innovative Point of Care technology as part of a pre-packaged UK administration sale, not the shares of the Cayman Islands entity LumiraDx Limited. Questions relating to the assignment of the transaction proceeds to LumiraDx 's creditors should therefore be directed to ...
LumiraDx
Login with LumiraDX Account. Username or email address. Password
LumiraDx
/en-uk/us-en
LumiraDx
Validate Access Code English (US). Copyright © 2024 - LumiraDx
Contact Us - United States - LumiraDx
Customer services: customerservices.us@ lumiradx.com 1-888-586-4721 Technical services: technicalservices.us@ lumiradx.com 1-888-586-4721 FULL LIST OF ADDRESSES
LumiraDx - LumiraDx Announces Agreement to Sell its Cutting …
LONDON, Dec. 29, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX) (the “Company”), a next generation point of care diagnostics company, announced today the appointment of joint administrators for two of its subsidiaries. The administrators have signed a definitive agreement to sell certain companies of the LumiraDx group related to LumiraDx’s innovative point of care technology ...
Next-generation diagnostic solutions | LumiraDx
With the compact LumiraDx Platform you get accurate lab-comparable results in minutes across a broad menu of tests including infectious disease, cardiovascular disease, diabetes and coagulation disorders.
Documentation Centre - LumiraDx
LumiraDx online documentation is accessible below - select the relevant dropdown to filter results. Language. Products « Vivre avec le COVID » aux urgences en 2022 : une biologie délocalisée efficiente et traçable - poster « Vivre avec le Covid » aux urgences en ...
LumiraDx - LumiraDx COVID-19 Antigen Test
The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens. For patients suspected of COVID-19 or asymptomatic indviduals, lab-comparable results in minutes.